Optimization of Infliximab Withdrawal Strategy for Rheumatoid Arthritis
NCT02770794 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 211
Last updated 2021-01-20
Summary
This multicenter prospective clinical trial investigates the accuracy of ultrasound to predict relapse after discontinuation of infliximab and the efficacy/safety of readministration of infliximab in patients with rheumatoid arthritis in a low disease activity state.
Conditions
- Arthritis, Rheumatoid
Interventions
- DRUG
-
Discontinue infliximab; receive Infliximab when relapse
Sponsors & Collaborators
-
Chiba University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-04-01
- Primary Completion
- 2020-08-14
- Completion
- 2020-08-14
Countries
- Japan
Study Locations
More Related Trials
-
A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).
NCT02222493 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.)
NCT00661284 ·Status: COMPLETED
-
A Study to Evaluate the Effectiveness of Infliximab and Changes in Hand and Wrist Magnetic Resonance Imaging (MRI) in Participants With Active Rheumatoid Arthritis (RA) (P08136)
NCT01313520 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis
NCT00036374 ·Status: COMPLETED ·Phase: PHASE3
-
Infliximab for the Treatment of Early Rheumatoid Arthritis
NCT00006292 ·Status: COMPLETED ·Phase: PHASE2
-
Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)
NCT03885037 ·Status: COMPLETED
-
A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDs
NCT02720523 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effectiveness and Safety of Early Treatment With Infliximab for Hip Arthritis Associated With Ankylosing Spondylitis (AS) (P06451)
NCT01148901 ·Status: WITHDRAWN ·Phase: PHASE4
-
An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants
NCT00760669 ·Status: COMPLETED
-
Long-term Treatment Study of Certolizumab Pegol Without Coadministration of Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients
NCT00850343 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis
NCT01927263 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Response to Tumor Necrosis Factor-alpha (TNF-alpha) Antagonists in Rheumatoid Arthritis.
NCT05379049 ·Status: UNKNOWN
-
Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid Arthritis
NCT00963703 ·Status: COMPLETED ·Phase: NA
-
Pharmaco Kinetic Variability of Infliximab in Rheumatoid Arthritis
NCT00840957 ·Status: COMPLETED
-
A Safety and Efficacy Study of Golimumab (CNTO 148) in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
NCT00727987 ·Status: COMPLETED ·Phase: PHASE3
-
Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis
NCT00213564 ·Status: COMPLETED
-
REMission INDuction in Very Early Rheumatoid Arthritis
NCT02935387 ·Status: TERMINATED ·Phase: PHASE4
-
Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk of Immunization in Rheumatoid Arthritis Patients or Juvenile Idiopathic Arthritis Patients
NCT02116504 ·Status: UNKNOWN ·Phase: NA
-
Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS)
NCT01220518 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis
NCT00439283 ·Status: COMPLETED ·Phase: PHASE3
-
Intraarticular Injection of Infliximab
NCT00521963 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis
NCT00244179 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.
NCT00207701 ·Status: COMPLETED ·Phase: PHASE3
-
Ultrasound Treatment of Rheumatoid Arthritis
NCT03690466 ·Status: COMPLETED ·Phase: NA
-
Study of MRA in Patients With Rheumatoid Arthritis (RA)
NCT00144651 ·Status: COMPLETED ·Phase: PHASE2